Cardiogenol C can induce Mouse Hair Bulge Progenitor Cells to Transdifferentiate into Cardiomyocyte-like Cells.
BACKGROUND
Hair bulge progenitor cells (HBPCs) are multipotent stem cells derived from the bulge region of mice vibrissal hairs. The purified HBPCs express CD34, K15 and K14 surface markers. It has been reported that HBPCs could be readily induced to transdifferentiate into adipocytes and osteocytes. However, the ability of HBPCs to transdifferentiate into cardiomyocytes has not yet been investigated.


RESULTS
The cardiomyogenic potential of HBPCs was investigated using a small cell-permeable molecule called Cardiogenol C. We established that Cardiogenol C could induce HBPCs to express transcription factors GATA4, Nkx2.5 and Tbx5, which are early specific markers for pre-cardiomyogenic cells. In prolonged cultures, the Cardiogenol C-treated HBPCs can also express muscle proteins, cardiac-specific troponin I and sarcomeric myosin heavy chain. However, we did not observe the ability of these cells to functionally contract. Hence, we called these cells cardiomyocyte-like cells rather than cardiomyocytes. We tried to remedy this deficiency by pre-treating HBPCs with Valproic acid first before exposing them to Cardiogenol C. This pretreatment inhibited, rather than improved, the effectiveness of Cardiogenol C in reprogramming the HBPCs. We used comparative proteomics to determine how Cardiogenol C worked by identifying proteins that were differentially expressed. We identified proteins that were involved in promoting cell differentiation, cardiomyocyte development and for the normal function of striated muscles. From those differentially expressed proteins, we further propose that Cardiogenol C might exert its effect by activating the Wnt signaling pathway through the suppression of Kremen1. In addition, by up-regulating the expression of chromatin remodeling proteins, SIK1 and Smarce1 would initiate cardiac differentiation.


CONCLUSIONS
In conclusion, our CD34+/K15+ HBPCs could be induced to transdifferentiate into cardiomyocyte-like cells using a small molecule called Cardiogenol C. The process involves activation of the Wnt signaling pathway and altered expression of several key chromatin remodeling proteins. The finding is clinically significant as HBPCs offer a readily accessible and autologous source of progenitor cells for cell-based therapy of heart disease, which is one of major killers in developed countries.
Stem Cell and Regeneration Thematic Research Programme, School of Biomedical Sciences, Chinese University of Hong Kong, Shatin, Hong Kong. kaholee@cuhk.edu.hk.
Winifred Wy
WW
Yau
Mei Kuen
MK
Tang
Elve
E
Chen
Yaoyao
Ivan Wc
IW
Wong
Henry Ss
HS
Lee
Kenneth Kh
KKh
Lee
EMBO J. 2007 Jan 24;26(2):358-70
17170704
Curr Biol. 1999 Jul 1;9(13):695-8
10395542
Nat Biotechnol. 2008 Nov;26(11):1269-75
18849973
Dev Dyn. 2004 Oct;231(2):258-69
15366003
Dev Biol. 1993 Jun;157(2):348-58
8099044
J Clin Invest. 2006 Jan;116(1):249-60
16395407
Ann Thorac Surg. 2003 Mar;75(3):775-9
12645692
Mol Cell Biol. 2004 Oct;24(19):8467-76
15367668
J Clin Invest. 2002 Jul;110(2):177-84
12122109
J Cell Physiol. 1993 Aug;156(2):219-25
8393876
Int J Biochem Cell Biol. 2007;39(12):2195-214
17625949
Pharmacol Ther. 2005 Aug;107(2):252-68
15925411
Exp Mol Med. 2004 Dec 31;36(6):515-23
15665584
Cell. 2006 Aug 25;126(4):663-76
16904174
J Cell Physiol. 1982 May;111(2):187-94
6177706
Proteomics. 2007 Jan;7(1):23-32
17154274
Cell. 2001 Jan 26;104(2):233-45
11207364
Nat Med. 2007 May;13(5):597-603
17468767
Cell Stem Cell. 2009 Feb 6;4(2):155-69
19200804
Nat Genet. 2002 May;31(1):25-32
11923873
N Engl J Med. 1999 Sep 2;341(10):738-46
10471461
Proteomics. 2006 Apr;6(8):2376-85
16518872
Genes Dev. 2006 May 1;20(9):1123-36
16618801
J Cell Biol. 2005 Sep 26;170(7):1135-46
16186259
Nat Biotechnol. 2007 Dec;25(12):1468-75
18037878
Circ Res. 2002 Sep 20;91(6):501-8
12242268
Nat Biotechnol. 2004 Apr;22(4):411-7
15024388
J Invest Dermatol. 2003 Apr;120(4):501-11
12648211
J Clin Invest. 1999 Mar;103(5):697-705
10074487
J Bone Miner Res. 2004 Jul;19(7):1128-36
15176996
Cell. 1990 Jun 29;61(7):1329-37
2364430
Proc Natl Acad Sci U S A. 2007 Jun 26;104(26):10894-9
17576928
Cell. 1999 Jul 9;98(1):37-46
10412979
J Biol Chem. 2005 Apr 29;280(17):16838-42
15701629
Proc Natl Acad Sci U S A. 2007 May 29;104(22):9313-8
17519333
Nature. 2002 Jun 6;417(6889):664-7
12050670
Nat Biotechnol. 2008 Jul;26(7):795-7
18568017
Biochem Biophys Res Commun. 2004 Dec 17;325(3):968-75
15541384
Nat Med. 2005 Dec;11(12):1351-4
16288281
Curr Opin Cell Biol. 2000 Dec;12(6):676-84
11063931
Nature. 2002 Aug 8;418(6898):636-41
12167861
Nature. 2004 Nov 4;432(7013):107-12
15525990
Proteomics. 2007 Dec;7(23):4303-16
17973295
Circ Res. 2006 Jul 7;99(1):15-24
16763166
Nature. 2006 May 18;441(7091):349-53
16625203
Cell. 2000 Jan 7;100(1):143-55
10647939
Development. 2001 Apr;128(7):1059-68
11245571
Genes Dev. 2003 Jan 1;17(1):126-40
12514105
EMBO J. 1997 Sep 15;16(18):5687-96
9312027
Anat Rec. 1999 Aug 15;257(4):137-48
10467245
Cardiovasc Res. 2008 Jul 1;79(1):24-33
18316325
Proc Natl Acad Sci U S A. 2003 May 13;100(10):5834-9
12719544
Development. 2002 Dec;129(24):5587-96
12421700
Mol Cell Biol. 1998 Aug;18(8):4807-18
9671490
Trends Cardiovasc Med. 1999 Jul;9(5):139-43
10639728
C R Biol. 2002 Oct;325(10):1027-38
12494500
J Am Chem Soc. 2004 Feb 18;126(6):1590-1
14871063